News

Biodefense Market Size worth $22.8 billion, Globally, by 2030 with 5% CAGR - Exclusive Study by The Research Insights
The global biodefense market size is projected to be valued at USD 16.1 billion in 2023 and reach USD 22.8 billion by 2030, ...
StockTake: Lumos enrols 500th patient in crucial respiratory diagnostic test study
Stockhead’s Tylah Tully unpacks the latest from Lumos Diagnostics (ASX:LDX), who have enrolled its 500th patient in a CLIA waiver study for FebriDx, its rapid point-of-care diagnostic test to ...
RiverBender.com1d
Duckworth, Warren Press RFK Jr. on “Dangerous War on Vaccines,” Reckless Decision to Slash HHS Vaccine Funding
WASHINGTON, D.C. U.S. Senators Tammy Duckworth (D-IL) and Elizabeth Warren (D-MA) wrote to U.S. Department of Health and ...
Morningstar5d
Emory University and Micron Biomedical Launch First-in-Human Clinical Trial of Next-Generation Rotavirus Vaccine Delivered via Dissolvable Microarray Technology
the Coalition for Epidemic Preparedness Innovations (CEPI), Biomedical Advanced Research and Development Authority (BARDA) and the Georgia Research Alliance. For more information visit ...
MedPage Today3d
Could Trump's War on Harvard Spell the End of U.S. Leadership in Science?
I was on the frontlines when COVID-19 hit and it felt like a surprise attack. Many academic research departments closed, but the Wyss Institute at Harvard, which I head, moved into high gear.
pharmaphorum4d
Vir awarded $1 billion multi-year BARDA influenza contract
The US Government’s Biomedical Advanced Research and Development Authority (BARDA) has made an initial investment of approximately $55 million for rapid development of VIR-2482, the Vir ...
Stockhead on MSN3d
Health Check: Mayne Pharma shareholders back $600m ‘phantom’ takeover offer
Mayne Pharma holders have voted overwhemingly in favour of Cosette's $600 million offer that's no longer on the table. See you in court.
MedPage Today on MSN6d
In Axing mRNA Contract, Trump Delivers New Blow to Biosecurity, Former Officials Say
The Trump administration's cancellation of $766 million in contracts to develop mRNA vaccines against potential pandemic flu ...
MedPage Today1d
Antiviral Reduced Transmission of Influenza to Close Contacts
and the Biomedical Advanced Research and Development Authority. Monto reported serving on an advisory committee for F. Hoffmann-La Roche. Co-authors reported relationships with F. Hoffmann-La ...
pharmaphorum1d
QuickFire Challenge deadline approaches for J&J BARDA Project NextGen accelerator
Johnson & Johnson Innovation and the Biomedical Advanced Research and Development Authority (BARDA) have announced the ‘Blue Knight Resident QuickFire Challenge: Accelerating Project NextGen’.
Marijuana Inc.: Exousia Pro Expands its Scientific Advisory Board
Dr. Marvin S. Hausman, MD, will be Chairman of the Scientific Advisory Board. ORLANDO, FLORIDA / ACCESS Newswire / June 18, 2025 / Exousia Pro, Inc. (OTCPINK:MAJI), a clinical-stage biotech company ut ...